Moderna and Coursera Launch Free Course on mRNA Technology
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/11/2026
- Wall St set to gain on tech rebound, Middle East in focus
- Oracle results beat estimates, but shares fall on plans for $40 billion raise
- Oil prices steady as investors weigh US-Iran war escalation
- Intel rallies as BofA double-upgrades stock on increased CPU, foundry visibility
- Oppenheimer sees little strategic case for Tesla-SpaceX merger
- Needham Starts Hyliion Holdings (HYLN) at Buy
- Oppenheimer Starts SpaceX (SPCX) at Outperform, PT $190, 'space infrastructure appears structurally advantaged'
- Alibaba falls on China AI capex report; Citi says selloff is premature
- Pentagon reportedly locked down, hazmat teams responding
- Crude Inventory Fell 7.2 Million Barrels Last Week, Says EIA
Moderna stock: What could trigger a turnaround over the next 3-6 months?
August 15, 2024 7:00 PM EDTModerna's (NASDAQ: MRNA) recent struggles have left investors wondering what could drive a turnaround in the company's stock over the next few months.
Following a turbulent second-quarter earnings report, which included a significant cut to 2024 sales guidance and a sharp decline in valuation, the focus has shifted to potential near-term catalysts.
According to Evercore ISI analysts, Moderna's story is currently... More
